Eli Lilly and Company LLY will release its fourth-quarter financial results, before the opening bell, on Thursday, Feb. 6, 2025. Analysts expect the Indianapolis, Indiana-based company to report ...

The Evangeline Parish Sheriff's Office is no longer being supervised by federal officials after officers detained people up to dozens of hours for witnessing crimes. The Department of Justice ...

JENNINGS, La. (KLFY) — The U.S. Department of Justice has closed a nearly ten-year investigation into illegal arrests conducted by the Evangeline Parish Sheriff’s Office. This comes after EPSO ...

VILLE PLATTE, La. (KLFY) — An Evangeline Parish Sheriff’s Deputy has been accused of inappropriate sexual contact with children, authorities said. Joshua Paul Uhlman, 36, of Pine Prairie ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

Black historical romance novelist Beverly Jenkins is known for centering Black love throughout history. This month, her work ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price target of $1,146.00. The company’s shares closed ...

Boris Becker's ex-wife Lilly has won the German version of I'm A Celebrity... Get Me Out Of Here! after stealing the hearts of the nation. The former Wimbledon tennis star, 57, has endured a ...

Jase May Boys Cross Country St. Mary's of Lancaster Ruby Nowak Girls Cross Country St. Mary's of Lancaster ...

Eli Lilly LLY-N on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about signs of weakness in sales of the drugs.